文献速递神经肿瘤

儿童脑肿瘤病毒免疫治疗的新兴领域

The emerging field of viroimmunotherapy for pediatric brain tumors.
PubMed 文献 · Neuro Oncol · 2024-01-01

儿童脑肿瘤是儿童最常见的实体瘤,部分类型如儿童型弥漫性高级别胶质瘤或中枢神经系统胚胎性肿瘤即使多模式治疗生存结局仍差。溶瘤病毒单用或联合其他治疗已在成人神经肿瘤学中使用,儿童脑肿瘤模型的临床前研究激增并推动临床转化取得鼓舞性结果。本综述总结儿童脑肿瘤临床前和临床研究中的不同病毒治疗,并讨论局限性和未来方向。

要点

  • 儿童脑肿瘤是儿童最常见的实体瘤,部分类型生存结局仍差。
  • 溶瘤病毒是脑肿瘤可行、安全且有前景的治疗,可直接细胞毒并激发抗肿瘤免疫。
  • 儿童脑肿瘤模型的临床前研究推动溶瘤病毒临床转化并取得鼓舞性结果。

核心结论

  • 溶瘤病毒是脑肿瘤可行、安全且有前景的治疗,儿童脑肿瘤的临床前和临床研究结果鼓舞。

研究设计与样本

  • 综述,总结儿童脑肿瘤临床前和临床研究中的不同病毒治疗。

主要发现

  • 儿童脑肿瘤是儿童最常见的实体瘤,部分类型如儿童型弥漫性高级别胶质瘤或中枢神经系统胚胎性肿瘤即使多模式治疗生存结局仍差。
  • 溶瘤病毒的直接细胞毒效应后,在某些情况下可激发抗肿瘤免疫反应,导致肿瘤部分或完全减瘤。
  • 溶瘤病毒单用或联合其他治疗主要用于成人神经肿瘤学,儿童脑肿瘤模型的临床前研究激增推动临床转化并取得鼓舞性结果。

局限性

  • 综述讨论改善这些肿瘤对病毒治疗反应所需的局限性和未来方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pediatric brain tumors are the most common solid tumors in children. Even to date, with the advances in multimodality therapeutic management, survival outcomes remain dismal in some types of tumors, such as pediatric-type diffuse high-grade gliomas or central nervous system embryonal tumors. Failure to understand the complex molecular heterogeneity and the elusive tumor and microenvironment interplay continues to undermine therapeutic efficacy. Developing a strategy that would improve survival for these fatal tumors remains unmet in pediatric neuro-oncology. Oncolytic viruses (OVs) are emerging as a feasible, safe, and promising therapy for brain tumors. The new paradigm in virotherapy implies that the direct cytopathic effect is followed, under certain circumstances, by an antitumor immune response responsible for the partial or complete debulking of the tumor mass. OVs alone or combined with other therapeutic modalities have been primarily used in adult neuro-oncology. A surge in encouraging preclinical studies in pediatric brain tumor models recently led to the clinical translation of OVs with encouraging results in these tumors. In this review, we summarize the different virotherapy tested in preclinical and clinical studies in pediatric brain tumors, and we discuss the limitations and future avenues necessary to improve the response of these tumors to this type of therapy.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Garcia-Moure M, Laspidea V, Gupta S, et al. The emerging field of viroimmunotherapy for pediatric brain tumors. Neuro Oncol. 2024. PMID: 39148489. doi:10.1093/neuonc/noae160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。